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Lifecourse socioeconomic status 
and type 2 diabetes: the role of 
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Silvia Stringhini1, Paola Zaninotto2, Meena Kumari3, Mika Kivimäki2 & G. David Batty2
We examined the association between lifecourse socioeconomic status (SES) and the risk of type 
2 diabetes at older ages, ascertaining the extent to which adult lifestyle factors and systemic 
inflammation explain this relationship. Data were drawn from the English Longitudinal Study of Ageing 
(ELSA) which, established in 2002, is a representative cohort study of ≥50-year olds individuals living 
in England. SES indicators were paternal social class, participants’ education, participants’ wealth, 
and a lifecourse socioeconomic index. Inflammatory markers (C-reactive protein and fibrinogen) and 
lifestyle factors were measured repeatedly; diabetes incidence (new cases) was monitored over 7.5 
years of follow-up. Of the 6218 individuals free from diabetes at baseline (44% women, mean aged 66 
years), 423 developed diabetes during follow-up. Relative to the most advantaged people, those in the 
lowest lifecourse SES group experienced more than double the risk of diabetes (hazard ratio 2.59; 95% 
Confidence Interval (CI) = 1.81–3.71). Lifestyle factors explained 52% (95%CI:30–85) and inflammatory 
markers 22% (95%CI:13–37) of this gradient. Similar results were apparent with the separate SES 
indicators. In a general population sample, socioeconomic inequalities in the risk of type 2 diabetes 
extend to older ages and appear to partially originate from socioeconomic variations in modifiable 
factors which include lifestyle and inflammation.
Based on Global Burden of Disease (GBD) estimates, type 2 diabetes (hereafter referred to as ‘diabetes’) has 
led to more than 12 million deaths in 2010, a 93% rise from 19901. Diabetes is also a major cause of disability, 
with an estimated 46,823 disability-adjusted years of life lost (DALYs) in 2010 (a 69% increase from 1990)2. 
While low socioeconomic status (SES) across the lifecourse has been found to be a major risk factor for the 
development of diabetes in adult life3–9, the mechanisms underlying this relationship are not fully understood4. 
Socioeconomic adversity in early life has been related to increased inflammatory activity in adult life10–15 and 
inflammation itself has been found to be associated with future diabetes risk16–18. Inflammation may also increase 
diabetes risk indirectly via other factors, including obesity19. Chronic inflammation may therefore be a mediator 
of the association between socioeconomic adversity and diabetes. Indeed, in the Whitehall II study of employed 
British middle-aged adults, chronic inflammation partially explained the association between lifecourse socio-
economic status and diabetes incidence5. However, it remains to be established whether the same factors explain 
socioeconomic differences in diabetes at older ages and in the general population which represents the full range 
of socioeconomic variation. The English Longitudinal Study of Ageing (ELSA) provides an opportunity to answer 
these questions. ELSA is also unusual in having repeated measurement of lifestyle risk factors for diabetes, such 
as obesity and physical activity, and inflammatory markers, allowing for more accurate characterisation of these 
potential explanatory variables than has previously been possible.
Data and Methods
Data are drawn from ELSA, a prospective cohort study of community-dwelling older people. Described in detail 
elsewhere20, ELSA was established in 2002 with a core sample of 11,391 women and men aged 50 years and 
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over, and was found to be representative of the national population in this age band living in private addresses 
in England20. Participants are contacted every 2 years for a follow-up interview and every 4 years for a medical 
examination. For the present analysis, ‘baseline’ was fixed at the ELSA wave 2 (2004/5) when biological data were 
first collected. ELSA was approved by the London Multicentre Research Ethics Committee (MREC/01/2/91) 
and informed consent was obtained from all participants. The methods were carried out in accordance with the 
approved guidelines.
Four indicators of socioeconomic status (SES) were used. Both paternal social class (high [managerial, pro-
fessional, and administrative occupations or business owners], intermediate [trade- and services related occupa-
tions], and low [manual and casual occupations and other occupations]), and education (high [finished full-time 
education at ≥ 17 years], intermediate [finished full-time education at 15–16 years], and low [finished full-time 
education at ≤ 14 years or no education]) were divided into three levels. Our third SES variable was total net 
non-pension household wealth which was categorised into tertiles and based on an estimation of the assets of 
study members and their partners, including properties, businesses, other assets, and any form of investments or 
savings (except for pension savings) less debts owed by them. The fourth SES indicator included was a composite 
lifecourse SES variable. To compute this, paternal social class, education and adult wealth were coded as 0–2 with 
higher values indicating greater disadvantage. The three SES indicators were then summed, resulting in a 7-level 
score with higher values corresponding to higher lifecourse disadvantage.
At study waves 2 (2004/5), 4 (2008/9) and 6 (2012/13) venous blood was taken by a research nurse. Using 
these data, diabetes was defined as blood glycated haemoglobin level (HbA1C) ≥ 48 mmol/mol (6.5%), following 
the World Health Organization (WHO) recommendations21. For participants with missing values on HbA1C, 
we used self-reported doctor-diagnosed diabetes, as we have previously4,8. The date of diabetes diagnosis was 
assigned according to the interval method, whereby the midpoint between the first visit with a diabetes diagnosis 
and the last visit without diabetes was used22.
C-reactive protein (CRP) was analyzed by using the N Latex CRP mono Immunoassay on the Behring 
Nephelometer II Analyzer (Dade Behring, Milton Keynes, UK). In all analyses, CRP data, originally skewed, were 
normalized using log-transformation. Participants with CRP levels > 10 mg/l were excluded from the analysis 
as they may indicate current infection instead of chronic inflammation. Fibrinogen was analyzed using a mod-
ification of the Clauss thrombin clotting method on the Organon Teknika MDA 180 analyzer. In all analyses, 
CRP and fibrinogen were treated as continuous variables. Current smoking was self-reported and classified as 
current, former, never smoker. Physical activity was assessed by asking participants how often they engaged in 
vigorous, moderate or mild physical activity. Three groups were the created: active (1/week), moderately active 
(1–3 times/month), and inactive (hardly ever/never). Alcohol intake was self-reported and classified < daily or 
daily. Height and weight were measured directly using standard procedures; Body Mass Index (BMI) was then 
computed and three classifications produced (< 25; 25–29; ≥ 30 kg/m2)23. Ethnicity (white/non-white), based on 
wave 2 data, as well as age and sex were treated as confounders in the analyses. All effect estimates were controlled 
for prevalent chronic illness (coronary heart disease, stroke and/or cancer) to account for the potential effect of 
these comorbidities.
Statistical analysis. Missing values for lifestyle factors and inflammatory markers were imputed using infor-
mation collected at the previous or successive wave. For those without information available at adjacent waves, 
multivariate imputation based on sex, age, ethnicity, lifestyle factors and inflammatory markers (Stata uvis proce-
dure) was used. Missing values on SES indicators and diabetes, our exposure and outcome, respectively, were not 
imputed. The association between SES and diabetes risk factors at baseline was examined using age-, sex-, ethnic-
ity and prevalent conditions adjusted logistic regressions for dichotomous variables (smoking, physical inactivity, 
alcohol consumption) and linear regressions for continuous variables (BMI, fibrinogen and CRP). Having ascer-
tained that the proportional hazard assumption had not been violated, Cox regressions were used to compute haz-
ard ratio (HR) with accompanying 95% confidence intervals (CI) for the association between lifecourse SES and 
diabetes. The association between SES and diabetes was first examined with a model including adjustment for age, 
ethnicity and an interaction term which was used to ascertain if sex modified the SES-diabetes relationship. As the 
effect of SES on type 2 diabetes did not differ by sex (p-value for interaction = 0.586), data were pooled and our 
effect estimates sex-adjusted (supplementary information). As tests did not suggest departure from a linear trend 
(p ≥ 0.05), SES indicators were entered into the models as continuous variables. The hazard ratio (HR) associated 
with a unit change in SES was modified in order to yield the HR in the lowest versus the highest SES category for 
each SES indicator. Each SES indicator was first entered in a basic model containing age, sex, ethnicity, and prev-
alent conditions (Model 1). Lifestyle factors and inflammatory markers (time-dependent covariates updated at 
waves 2 and 4) were then entered individually and simultaneously into Model 1. Further, to account for long-term 
exposure to these risk factors, at each follow-up period we controlled not only for the risk factor at the current 
wave but also for the risk factors at previous waves, as we have previously5. The contribution of risk factors in 
explaining the SES- diabetes association was determined by the percent attenuation in the β coefficient for SES 
after inclusion of the risk factor in question to Model 1: “100 × (β Model 1 − β Model 1+risk factor(s))/(β Model 1)”. The inde-
pendent contribution of inflammatory markers (from lifestyle factors) is calculated as “100 × (β Model 1+lifestyle factors − 
β Model 1+all factors)/(β Model 1+lifestyle factors)”. We calculated a 95% confidence interval (CI) around the percentage atten-
uation using a bootstrap method with 1000 re-samplings.
Results
A total of 8688 participants attended ELSA wave 2 (study baseline). Of these, 2470 were excluded because of miss-
ing values (missingness was not mutually exclusive) on socioeconomic indicators (N = 89), behavioural factors 
or inflammatory markers (N = 1028), unknown diabetes status (N = 10), prevalent diabetes at baseline (N = 800) 
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or CRP levels ≥ 10 mg/l (N = 1626). Excluded participants were older, more likely to be women, and had a lower 
SES (p < 0.05), although absolute differences were small.
In Table 1 we summarise the baseline characteristics of the 6218 participants included in the present anal-
ysis, 423 of whom developed diabetes over the 7.5 years mean follow-up (diabetes incidence rate 9.0 per 1000 
person-years). Mean age at baseline was 65.8 years, 44% of participants were women, and the large majority was 
white European. A total of 14.2% of study members reported chronic disease conditions, the prevalence being 
highest in the lower SES groups (p < 0.05). Diabetes incidence was inversely associated with SES, such that high-
est rates were apparent among the disadvantaged as indexed by paternal social class, adult wealth, education, and 
lifecourse SES. With the exception of education, these effects were incremental across the full socioeconomic 
range.
The association between lifecourse socioeconomic indicators and diabetes risk factors at baseline is presented 
in Table 2. For the four SES indicators, individuals with a lowest vs highest SES were more likely to be smokers 
(OR = 8.90, 95%CI:6.60;12.0 for lifecourse SES score) and physically inactive (OR = 5.67, 95%CI:4.21;7.67 for 
lifecourse SES score), but less likely to consume alcohol frequently (OR = 0.17, 95%CI:0.13;0.21 for lifecourse 
SES score). They also had a higher BMI (β = 2.16, 95%CI:1.74;2.59 for lifecourse SES score), fibrinogen (β = 0.28, 
95%CI:0.22;0.33 for lifecourse SES score) and CRP levels (β = 0.57, 95%CI:0.49;0.63 for lifecourse SES score).
In Fig. 1 we show the age-, sex-, ethnicity- and prevalent health conditions-adjusted associations of SES indi-
cators with diabetes incidence, together with the relative contribution of lifestyle factors and inflammatory mark-
ers to these gradients. Individuals in the most disadvantaged SES groups experienced a higher risk of developing 
diabetes during follow-up compared to those with the most advantaged groups for paternal social class (HR; 95% 
CI:1.56; 1.23–1.97), education (1.76; 1.39–2.24) and wealth (2.59; 1.82–3.71). Adding lifestyle factors to the mul-
tivariable models resulted in marked attenuation ranging from 41–65% depending on the SES indicator, whereas 
the explanatory power of inflammatory markers was more modest (16–32%). The additional contribution of 
inflammatory markers to the model already adjusted for lifestyle factors was 3% for paternal social class, 18% for 
education, 11% for wealth and 8% for lifecourse SES.
Discussion
In this representative sample of the older English population, various indicators of low socioeconomic status 
across the lifecourse were related to an increased risk of later diabetes. Chronic inflammation explained up to 
N (%) Age Mean (SD) Men N (%) White N (%)
Existing 
illness N (%)
Diabetes 
incidence N 
(rateb)
Paternal social class
 High 1951 (31.4) 65.4 (8.7) 1147 (58.8) 1901 (97.4) 268 (13.7) 109 (6.4)
 Middle 2009 (32.3) 65.9 (9.4) 1098 (54.7) 1994 (99.3) 271 (13.5) 128 (9.8)
 Low 2258 (36.3) 66.2 (10.3) 1240 (54.9) 2221 (98.4) 343 (15.2) 186 (12.2)
 p-valuea 0.010 0.013 < 0.001 0.224 0.002
Education
 High 1848 (29.7) 63.9 (9.2) 1031 (55.8) 1786 (96.7) 204 (11.0) 96 (6.6)
 Middle 3250 (52.3) 63.6 (7.9) 1839 (56.6) 3222 (99.1) 418 (12.9) 249 (10.5)
 Low 1120 (18.0) 75.7 (7.8) 615 (54.9) 1108 (98.9) 260 (23.2) 78 (9.7)
 p-value < 0.001 0.681 < 0.001 < 0.001 0.076
Adult wealth
 High 2298 (37.0) 64.7 (8.8) 1220 (53.1) 2266 (98.6) 267 (11.6) 148 (6.6)
 Middle 2136 (34.3) 65.7 (9.4) 1191 (55.8) 2114 (98.9) 306 (14.3) 98 (10.2)
 Low 1783 (28.7) 67.5 (10.2) 1073 (60.2) 1735 (97.3) 309 (17.3) 177 (12.1)
 p-value < 0.001 < 0.001 < 0.001 < 0.001 0.001
Lifecourse SES
 0 (Highest) 668 (10.7) 63.6 (8.5) 378 (56.6) 651 (97.5) 67 (10.0) 27 (5.3)
 1 845 (13.6) 64.3 (9.0) 466 (55.2) 830 (98.2) 100 (11.8) 40 (5.7)
 2 1065 (17.1) 64.7 (9.0) 567 (53.2) 1043 (97.9) 134 (12.6) 75 (9.2)
 3 1263 (20.3) 64.9 (8.9) 740 (58.6) 1249 (98.9) 165 (13.1) 79 (8.4)
 4 1215 (19.5) 66.0 (9.3) 664 (54.7) 1198 (98.6) 194 (15.9) 98 (11.0)
 5 876 (14.1) 68.3 (10.0) 509 (58.1) 864 (98.6) 152 (17.3) 78 (14.2)
 6 (Lowest) 285 (4.6) 76.3 (8.2) 160 (56.1) 280 (98.3) 70 (24.6) 26 (14.8)
 p-value < 0.001 0.113 0.257 < 0.001 0.001
Overall 6218 65.8 (9.5) 3485 (56.1) 6116 (98.4) 882 (14.2) 423 (9.0)
Table 1.  Study participant characteristics at baseline and diabetes incidence at 7.5-year follow-up 
according to indicators of socioeconomic status in early and adult life. The English Longitudinal Study 
of Ageing (2004–2013). CI, 95% confidence interval; SD, standard deviation. ap-value for linear trend across 
socioeconomic categories. bAge- and sex-adjusted incidence rate per 1000 person-years over a 7.5 years mean 
follow-up.
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Lowest vs highest 
paternal social class
Lowest vs highest 
education
Lowest vs highest 
adult wealth
Lowest vs highest 
lifecourse SES
ORa (95% CI) ORa (95% CI) ORa (95% CI) ORa (95% CI)
Current smoking (Ref.: never/
former smoking) 1.84 (1.54; 2.21) 3.10 (2.40; 4.02) 4.87 (4.00; 5.91) 8.90 (6.60; 12.0)
Sedentary (Ref.: moderately 
active/active) 1.53 (1.27; 1.85) 2.49 (1.97; 3.15) 3.89 (3.16; 4.77) 5.67 (4.21; 7.67)
Frequent alcohol consumption 
(Ref.: less than daily) 0.53 (0.47; 0.61) 0.31 (0.26; 0.38) 0.33 (0.29; 0.38) 0.17 (0.13; 0.21)
βa (95% CI) βa (95% CI) βa (95% CI) βa (95% CI)
Body mass index 0.96 (0.69; 1.25) 1.13 (0.77; 1.49) 1.32 (1.03; 1.61) 2.16 (1.74; 2.59)
Fibrinogen 0.11 (0.08; 0.15) 0.14 (0.10; 0.19) 0.18 (0.15; 0.22) 0.28 (0.22; 0.33)
 CRP 0.19 (0.14; 0.25) 0.35 (0.28; 0.42) 0.38 (0.32; 0.43) 0.57 (0.49; 0.63)
Table 2.  Association between lifecourse socioeconomic indicators and diabetes risk factors at baseline. The 
English Longitudinal Study of Ageing (2004–2013). β : Beta coefficient; CI: Confidence Interval; CRP: C-reactive 
protein; OR: Odds Ratio; Ref: Reference. aEffect estimates adjusted for age, sex, ethnicity and prevalent chronic 
disease.
Figure 1. Hazard ratios (95% confidence intervals) for the relation of different indicators of SES with 
diabetes incidence. The English Longitudinal Study of Ageing 2004–2013. Hazard ratios are for the lowest 
vs. highest SES category. From top to bottom, the first bars shows hazard ratios for the relation of each SES 
indicator with diabetes, adjusted for age, sex, ethnicity and prevalent disease (model 1). The second bars show 
Model 1 with the addition of lifestyle factors (smoking, alcohol intake, physical activity, BMI); the third bars 
Model 1 with the addition of inflammatory markers (CRP and fibrinogen); and the fourth bars Model 1 with the 
combined addition of lifestyle factors and inflammatory markers. The contribution of inflammatory markers to 
the SES-diabetes gradient, independent from lifestyle factors, is 3% for paternal social class, 18% for education, 
11% for wealth and 8% for lifecourse SES.
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one third of this association, while lifestyle factors explained up to two thirds, suggesting that much of these 
differences are modifiable. To our knowledge, this is the first examination of the explanatory power of systemic 
inflammation in the SES-diabetes relation in a population-representative sample of older ages. A further unusual 
feature of the present study was the repeat assessment of lifestyle and inflammatory markers during follow-up, 
thus reducing measurement error and accounting for potential changes in time-varying characteristics.
Our findings have important implications as recent studies suggest that gene regulation of the immune func-
tion may be one of the pathways through which socioeconomic status across the lifecourse is biologically embed-
ded10,24. There are at least two biological explanations for the apparent mediating role of inflammation in the 
lifecourse SES- diabetes association. First, SES could affect inflammation through stress-mediated factors involv-
ing the hypothalamic-pituitary-adrenal axis and the autonomic nervous system11,12. Recent evidence reporting 
SES-related epigenetic changes in genomic regions regulating response to stress supports this possibility24–26. 
Second, inflammatory processes are related to several risk factors for diabetes that are strongly patterned by SES, 
such as obesity, unhealthy diet, and physical inactivity27–29. In addition, chronic stress in people experiencing 
socioeconomic adversity may influence lifestyle factors and inflammatory activity30. Finally, whether socioeco-
nomic differences in inflammation arise late in life as a consequence of unhealthy behaviors and chronic stress, 
or are set in early life through an epigenetic programming of a defensive phenotype driven by adverse early life 
conditions, remains a matter of debate. Our findings of an independent contribution of inflammation (from 
lifestyle factors) to social inequalities in diabetes incidence and the stronger associations observed for the life-
course SES indicator compared to childhood or adulthood SES indicators suggest that both mechanisms may 
be at play. Studies which capture additional inflammatory markers, such as interleukins and TNF-α , are now 
needed in order to obtain a more precise estimation of their role in social inequalities in type 2 diabetes and other 
inflammation-related diseases.
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